Total submissions: 1
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Ambry Genetics | RCV004455012 | SCV004946150 | uncertain significance | not specified | 2023-12-30 | criteria provided, single submitter | clinical testing | The c.364A>G (p.K122E) alteration is located in exon 1 (coding exon 1) of the SCP2D1 gene. This alteration results from a A to G substitution at nucleotide position 364, causing the lysine (K) at amino acid position 122 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |